Nyrada
Menu
NYR:
Market Cap*:
Price Delay ~20min
Home
About Us
Company Overview
Board of Directors
Management
Scientific Advisory Board
Corporate Governance
Our Science
Lead Drug Development
Cardiovascular
Neuroprotection
Drug Discovery
Inflammation/Pain
Autoimmune
Technical Glossary
Publications
Investors
Investor Welcome
ASX Announcements
Share Price Information
Shareholder Meetings
Key Dates
Investors Glossary
Financial Reports
Annual Reports
Analyst Reports
News & Insights
Presentations & Interviews
Media
Newsletters
Contact Us
Contact Us
Working at Nyrada
Email Alerts
Investors
Home
>
Investors
>
ASX Announcements
Investor Welcome
ASX Announcements
Share Price Information
Shareholder Meetings
Key Dates
Investors Glossary
Financial Reports
Annual Reports
Analyst Reports
ASX Announcements
Filter by Year:
2022
2021
2020
24-Feb-2021
Appendix 3G
24-Feb-2021
Change of Director's Interest Notice - MF
23-Feb-2021
Investor Presentation to Finance News Network CEO Showcase
22-Feb-2021
Nyrada Reports Half Year FY2021 Results
22-Feb-2021
Appendix 4D and Half Year Accounts
16-Feb-2021
Lapsing of balance of Unlisted SAB Options
16-Feb-2021
Cleansing Statement
16-Feb-2021
Appendix 2A
1-Feb-2021
NYR Secures Collaboration with Walter Reed and UNSW
29-Jan-2021
Trading Halt
Previous
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
Next
